Montgomery Susan P, Chow Catherine C, Smith Stephanie W, Marfin Anthony A, O'Leary Daniel R, Campbell Grant L
Arbovirus Diseases Branch, Division of Vector-Borne Infectious Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC), Fort Collins, Colorado, USA.
Vector Borne Zoonotic Dis. 2005 Fall;5(3):252-7. doi: 10.1089/vbz.2005.5.252.
Since 1999, more than 6,500 cases of West Nile virus neuroinvasive disease (WNND) have been reported in the United States. Patients with WNND can present with muscle weakness that is often assumed to be of neurological origin. During 2002, nearly 3,000 persons with WNV meningitis or encephalitis (or both) were reported in the United States; in suburban Cook County, Illinois, with 244 persons were hospitalized for WNV illnesses. The objective of this investigation was to describe the clinical and epidemiological features of identified cases of WNV neuroinvasive disease and rhabdomyolysis. Public health officials investigated patients hospitalized in Cook County, and identified a subset of WNV neuroinvasive disease patients with elevated creatine kinase levels. Cases were defined as hospitalized persons with a WNV infection, encephalitis or meningitis, and rhabdomyolysis. Retrospective medical record reviews were conducted and data was abstracted with a standardized data collection instrument. Eight patients with West Nile encephalitis and one with West Nile meningitis were identified with rhabdomyolysis. Median age of the nine patients was 70 years (range, 45-85 years), and eight were men. For all nine patients, the peak CK level was documented a median of 2 days after hospitalization (range, 1-24 days). Median CK level during hospitalization for all case-patients was 3,037 IU (range, 1,153-42,113 IU). Six patients had history of recent falls prior to admission. Although the temporal relationship of rhabdomyolysis and neurological WNV illness suggested a common etiology, these patients presented with complex clinical conditions which may have led to development of rhabdomyolysis from other causes. The spectrum of WNV disease requires further investigation to describe this and other clinical conditions associated with WNV infection.
自1999年以来,美国已报告6500多例西尼罗河病毒神经侵袭性疾病(WNND)。WNND患者可能出现肌肉无力,通常认为这是神经源性的。2002年期间,美国报告了近3000例西尼罗河病毒脑膜炎或脑炎(或两者兼有)患者;在伊利诺伊州库克县郊区,有244人因西尼罗河病毒疾病住院。本调查的目的是描述已确诊的西尼罗河病毒神经侵袭性疾病和横纹肌溶解病例的临床和流行病学特征。公共卫生官员对库克县住院的患者进行了调查,并确定了一组肌酸激酶水平升高的西尼罗河病毒神经侵袭性疾病患者。病例定义为患有西尼罗河病毒感染、脑炎或脑膜炎以及横纹肌溶解的住院患者。进行了回顾性病历审查,并使用标准化数据收集工具提取数据。8例西尼罗河脑炎患者和1例西尼罗河脑膜炎患者被确诊为横纹肌溶解。9例患者的中位年龄为70岁(范围45 - 85岁),8例为男性。所有9例患者的肌酸激酶(CK)水平峰值记录在住院后中位数2天(范围1 - 24天)。所有病例患者住院期间的CK水平中位数为3037 IU(范围1153 - 42113 IU)。6例患者在入院前近期有跌倒史。尽管横纹肌溶解与西尼罗河病毒神经疾病的时间关系提示有共同病因,但这些患者呈现出复杂的临床状况,可能由其他原因导致横纹肌溶解。西尼罗河病毒疾病的范围需要进一步调查,以描述这种情况以及与西尼罗河病毒感染相关的其他临床状况。